Anti-Human SLC39A6 Antibody (SAA1475)

Catalog No.

FHG52910

Species reactivity

Human

Host species

Human

Isotype

IgG1, kappa

Clonality

Monoclonal

Conjugation

Unconjugated

Target

SLC39A6, LIV1, Zrt- and Irt-like protein 6, Zinc transporter ZIP6, ZIP-6, Estrogen-regulated protein LIV-1, Solute carrier family 39 member 6, ZIP6

Concentration

2.87 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q13433

Applications

ELISA, FCM, Neutralization

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

SAA1475

Zinc transporter ZnT5 is associated with epithelial mesenchymal transition via SMAD1 in breast cancer., PMID:39138630

Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response., PMID:38992028

Expression of cell surface zinc transporter LIV1 in triple negative breast cancer is an indicator of poor prognosis and therapy failure., PMID:38345361

Prognostic and Predictive Value of LIV1 Expression in Early Breast Cancer and by Molecular Subtype., PMID:36986799

Zinc transporter LIV1: A promising cell surface target for triple negative breast cancer., PMID:36181695

The importance of targeting signalling mechanisms of the SLC39A family of zinc transporters to inhibit endocrine resistant breast cancer., PMID:35591900

Genomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast Cancer., PMID:33782032

The ZIP6/ZIP10 heteromer is essential for the zinc-mediated trigger of mitosis., PMID:32797246

Recombinant Expression of Zinc Transporter SLC39A6 and Its Functional Antibody Production., PMID:31009334

SGN-LIV1A: a novel antibody-drug conjugate targeting LIV-1 for the treatment of metastatic breast cancer., PMID:25253783

LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling., PMID:22110740

Concordant correlation of LIV-1 and E-cadherin expression in human breast cancer cell MCF-7., PMID:18330719

Document Download

Anti-Human SLC39A6 Antibody (SAA1475).pdf